Sale Of Pfizer’s Established Products Not Off The Table, Exec Says
This article was originally published in PharmAsia News
Executive Summary
Pfizer CFO Frank D’Amelio talks about the big pharma’s long-term vision and cost-reduction initiatives during the Morgan Stanley Healthcare conference. Management will continue reviewing the portfolio on an ongoing basis to see how best to maximize shareholder value, he said.